EDGAR Filing Documents for 0001206774-09-000907

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001206774-09-000907

Filing Date

2009-04-30

Accepted

2009-04-30 07:00:35

Documents

Period of Report

2009-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	regeneron_10q.htm	10-Q	423315
2	FORM OF OPTION AGREEMENT AND RELATED NOTICE OF GRANT FOR USE IN CONNECTION	exhibit10-1.htm	EX-10.1	31919
3	FORM OF OPTION AGREEMENT AND RELATED NOTICE OF GRANT FOR USE IN CONNECTION	exhibit10-2.htm	EX-10.2	36305
4	THIRD AMENDMENT TO LEASE, BY AND BETWEEN BMR-LANDMARK	exhibit10-3.htm	EX-10.3	143266
5	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE	exhibit31-1.htm	EX-31.1	7951
6	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE	exhibit31-2.htm	EX-31.2	8341
7	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350.	exhibit32.htm	EX-32	3237
	Complete submission text file	0001206774-09-000907.txt		655636

Mailing Address

Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)